Drupal.behaviors.print = function(context) {window.print();window.close();}>
Genomic Health's Q1 Revenues Climb 17 Percent, Net Loss Turns to Profit
May 03, 2012
Genomic Health's Q1 Revenues Climb 17 Percent, Net Loss Turns to Profit
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
UK's NICE Recommends Use of Genomic Health's OncoType DX in Draft Guidance
February 19, 2013 / GenomeWeb Daily News
Vermillion's OVA1 Sales Increase 8 Percent in Q1
May 16, 2013 / GenomeWeb Daily News
Medicare to Cover Genomic Health's Oncotype DX Breast Cancer Test for DCIS
May 13, 2013 / GenomeWeb Daily News
Nanosphere Q1 Revenues Rise 85 Percent; Secures $27M in Financing
May 8, 2013 / GenomeWeb Daily News
Genomic Health Reports 8 Percent Jump in Q1 Revenues
May 3, 2013 / GenomeWeb Daily News